Re-Vana Therapeutics
Jenna Hewitt serves as the Director of Program Management at Re-Vana Therapeutics since July 2023. Previously, Jenna held the position of R&D Director at Fusion Antibodies from November 2020 to June 2023, where responsibilities included leading discovery projects, expanding the R&D team, managing collaborations with prestigious institutions, and overseeing various research initiatives. Prior to this role, Jenna managed R&D projects at Norbrook Laboratories Ltd and Almac Group, focusing on new product development and project management methodologies. Additional experience includes positions at Oxford Genetics Ltd, Green Biologics Ltd, and MedImmune, combined with an adventurous year-long backpacking trip. Jenna holds a BSc (Hons) in Forensic Science from Abertay University.
This person is not in any teams
Re-Vana Therapeutics
Re-Vana Therapeutics is an ocular pharmaceutical and drug delivery company focused on the development and commercialisation of revolutionary long-acting biodegradable drug delivery platforms to treat chronic eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma and ocular infections.